BACKGROUND:Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS:We draw upon data from the Treatment Episode Data Set-Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS:Estimates from logistic regression models highlight certain groups which show lower odds of receipt of O...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
Abstract Background Incarcerated populations experien...
Objective: To identify the geographic, organisational, and payment correlates of buprenorphine and m...
BACKGROUND:Access to adequate treatment for opioid use disorder (OUD) has been a high priority among...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
Background: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
OBJECTIVE: To determine access to opioid agonist therapy (OAT) for those entering residential treatm...
OBJECTIVE: To determine access to opioid agonist therapy (OAT) for those entering residential treatm...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
Abstract Background Incarcerated populations experien...
Objective: To identify the geographic, organisational, and payment correlates of buprenorphine and m...
BACKGROUND:Access to adequate treatment for opioid use disorder (OUD) has been a high priority among...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
Background: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority amon...
OBJECTIVE: To determine access to opioid agonist therapy (OAT) for those entering residential treatm...
OBJECTIVE: To determine access to opioid agonist therapy (OAT) for those entering residential treatm...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
Abstract Background Incarcerated populations experien...
Objective: To identify the geographic, organisational, and payment correlates of buprenorphine and m...